VBI Vaccines Inc. (Nasdaq: VBIV) (“VBI”) is scheduled to present at the Sachs Associates’ 15th Annual Biotech in Europe Forum on Tuesday, September 29th, 2015 at 6:45 AM ET (12:45 PM CEST). The event is being held at the Congress Center Basel in Basel, Switzerland.
Jeff Baxter, VBI’s President and CEO, will provide an overview of VBI's business during his presentation. In addition, Mr. Baxter will participate in a vaccines panel discussion on September 29th, 2015 at 3:45 AM ET (9:45 AM CEST).
The Biotech in Europe Forum brings together a cross-section of early-stage, late-stage, and public companies with leading investors, analysts, money managers, and pharmaceutical licensing executives. For more information, visit: http://bit.ly/sachs-2015